# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-17-005713
Filing Date
2017-03-31
Accepted
2017-03-31 11:55:38
Documents
92
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20161231_10k.htm | 10-K | 1723825
2 | EXHIBIT 3.1 | ex3-1.htm | EX-3.1 | 35229
3 | EXHIBIT 10.5 | ex10-5.htm | EX-10.5 | 77900
4 | EXHIBIT 10.17 | ex10-17.htm | EX-10.17 | 32007
5 | EXHIBIT 21.1 | ex21-1.htm | EX-21.1 | 11277
6 | EXHIBIT 23.1 | ex23-1.htm | EX-23.1 | 3906
7 | EXHIBIT 31.1 | ex31-1.htm | EX-31.1 | 15962
8 | EXHIBIT 31.2 | ex31-2.htm | EX-31.2 | 15933
9 | EXHIBIT 32.1 | ex32-1.htm | EX-32.1 | 10991
16 |  | dffn20161231_10kimg011.jpg | GRAPHIC | 15270
17 |  | chart.jpg | GRAPHIC | 59126
18 |  | dffn20161231_10kimg009.gif | GRAPHIC | 21678
19 |  | dffn20161231_10kimg008.jpg | GRAPHIC | 26866
20 |  | dffn20161231_10kimg007.jpg | GRAPHIC | 19129
| Complete submission text file | 0001437749-17-005713.txt |  | 7324054

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EXHIBIT 101.INS | dffn-20161231.xml | EX-101.INS | 1264799
11 | EXHIBIT 101.SCH | dffn-20161231.xsd | EX-101.SCH | 68981
12 | EXHIBIT 101.CAL | dffn-20161231_cal.xml | EX-101.CAL | 32760
13 | EXHIBIT 101.DEF | dffn-20161231_def.xml | EX-101.DEF | 528456
14 | EXHIBIT 101.LAB | dffn-20161231_lab.xml | EX-101.LAB | 392429
15 | EXHIBIT 101.PRE | dffn-20161231_pre.xml | EX-101.PRE | 542573

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 17728941
SIC: 2834 Pharmaceutical Preparations